Anchor Investment Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$12.1M Sell
13,180
-248
-2% -$251K 1.01% 20
2025
Q4
$14.4M Sell
13,428
-822
-6% -$786K 1.17% 19
2025
Q3
$10.9M Buy
14,250
+196
+1% +$146K 0.9% 23
2025
Q2
$11M Buy
14,054
+38
+0.3% +$29.5K 0.96% 20
2025
Q1
$11.6M Sell
14,016
-29
-0.2% -$24.1K 1.08% 19
2024
Q4
$10.8M Buy
14,045
+95
+0.7% +$78.7K 1.01% 22
2024
Q3
$12.4M Sell
13,950
-16
-0.1% -$14.4K 1.17% 18
2024
Q2
$12.6M Buy
13,966
+131
+0.9% +$105K 1.3% 16
2024
Q1
$10.8M Sell
13,835
-374
-3% -$266K 1.13% 19
2023
Q4
$8.28M Buy
14,209
+249
+2% +$145K 0.95% 24
2023
Q3
$7.5M Buy
13,960
+96
+0.7% +$49.5K 0.98% 23
2023
Q2
$6.5M Buy
13,864
+419
+3% +$176K 0.83% 30
2023
Q1
$4.62M Buy
13,445
+46
+0.3% +$15.5K 0.63% 42
2022
Q4
$4.9M Sell
13,399
-501
-4% -$178K 0.7% 35
2022
Q3
$4.49M Sell
13,900
-121
-0.9% -$38.3K 0.7% 36
2022
Q2
$4.55M Sell
14,021
-157
-1% -$47.1K 0.66% 39
2022
Q1
$4.06M Sell
14,178
-828
-6% -$213K 0.51% 53
2021
Q4
$4.14M Buy
15,006
+158
+1% +$40.1K 0.51% 55
2021
Q3
$3.43M Buy
14,848
+79
+0.5% +$19.5K 0.48% 62
2021
Q2
$3.39M Buy
14,769
+222
+2% +$44.6K 0.47% 64
2021
Q1
$2.72M Buy
14,547
+70
+0.5% +$13.7K 0.41% 69
2020
Q4
$2.44M Buy
14,477
+1,200
+9% +$179K 0.44% 71
2020
Q3
$1.97M Hold
13,277
0.4% 72
2020
Q2
$2.18M Hold
13,277
0.49% 60
2020
Q1
$1.84M Buy
13,277
+813
+7% +$112K 0.48% 65
2019
Q4
$1.64M Buy
12,464
+1,000
+9% +$116K 0.35% 88
2019
Q3
$1.28M Buy
11,464
+25
+0.2% +$2.78K 0.3% 101
2019
Q2
$1.27M Hold
11,439
0.3% 93
2019
Q1
$1.48M Hold
11,439
0.37% 77
2018
Q4
$1.32M Sell
11,439
-4,200
-27% -$469K 0.38% 75
2018
Q3
$1.68M Sell
15,639
-500
-3% -$50K 0.38% 75
2018
Q2
$1.38M Buy
16,139
+433
+3% +$35.6K 0.34% 82
2018
Q1
$1.22M Hold
15,706
0.32% 90
2017
Q4
$1.33M Hold
15,706
0.35% 81
2017
Q3
$1.34M Hold
15,706
0.39% 74
2017
Q2
$1.29M Sell
15,706
-200
-1% -$16.3K 0.43% 70
2017
Q1
$1.34M Buy
15,906
+1,400
+10% +$112K 0.46% 65
2016
Q4
$1.07M Sell
14,506
-100
-0.7% -$7.45K 0.4% 74
2016
Q3
$1.17M Buy
14,606
+1,500
+11% +$120K 0.45% 68
2016
Q2
$1.03M Buy
13,106
+2,400
+22% +$181K 0.41% 74
2016
Q1
$771K Buy
+10,706
New +$810K 0.32% 86

Other funds holding LLY

Anchor Investment Management's LLY Position: Q1 2026 in Review

Anchor Investment Management reduced its Eli Lilly (LLY) stake by 1.8% in Q1 2026, selling an estimated $251K and leaving 13,180 shares worth $12.1M. The position accounts for 1.01% of the portfolio, ranked #20.

Anchor Investment Management first reported a position in LLY in Q1 2016 and has held it in 41 quarters since. The position peaked at $14.4M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Anchor Investment Management held 13,180 shares of Eli Lilly worth $12.1M as of Q1 2026.
  • Anchor Investment Management sold 248 Eli Lilly shares in Q1 2026, an estimated $251K.
  • Eli Lilly made up 1.01% of Anchor Investment Management's portfolio in Q1 2026, its #20 holding.
  • Anchor Investment Management first reported a position in Eli Lilly in Q1 2016 and has held it in 41 quarters since.
  • Anchor Investment Management's Eli Lilly position peaked at $14.4M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Anchor Investment Management's 13F filing for Q1 2026, filed 1 May 2026.